Physician profile
Amy E Bohan
NPI 1477554285
$16,952.73
in general payments reported to CMS, 2019-2025
47 companies · $3,284 in 2025
The $3,284 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,021 · 2020: $422 · 2021: $2,164 · 2022: $3,396 · 2023: $2,697 · 2024: $2,968 · 2025: $3,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,892 · Education: $57.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,891.64 |
| Education | $57.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,665.23 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $1,921.02 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $1,343.67 | 2019-2025 | Dupixent |
| Genzyme Corporation | $1,302.96 | 2019-2025 | |
| Mylan Specialty L.P. | $791.37 | 2019-2024 | Yupelri |
| Insmed, INC. | $769.44 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $767.38 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Actelion Pharmaceuticals US, INC. | $735.61 | 2019-2025 | Opsumit, Uptravi |
| Grifols USA, LLC | $634.22 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $614.14 | 2021-2025 | Acthar |
| Jazz Pharmaceuticals INC. | $528.65 | 2021-2025 | |
| Amgen INC. | $500.85 | 2021-2025 | Tezspire, Tavneos |
| Electromed, INC. | $445.65 | 2021-2025 | Smartvest |
| Ethicon INC. | $357.65 | 2022-2024 | Monarch Platform |
| Pulmonx Corporation | $346.00 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $310.23 | 2019-2025 | Incourage Airway Clearance Therapy, (Ak6) Vest Therapy |
| Baxter Healthcare | $297.94 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Harmony Biosciences LLC | $219.81 | 2021-2025 | Wakix |
| Genentech USA, INC. | $215.10 | 2019-2025 | Xolair |
| Sunovion Pharmaceuticals INC. | $179.29 | 2019-2020 | |
| United Therapeutics Corporation | $169.48 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Takeda Pharmaceuticals U.S.A., INC. | $162.99 | 2021-2023 | Glassia |
| Teva Pharmaceuticals USA, INC. | $155.92 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $154.38 | 2024-2025 | Lumryz |
| Viatris Specialty LLC | $151.44 | 2025 | Yupelri |
| Verona Pharma, INC. | $144.77 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $122.45 | 2019-2024 | |
| Inogen, INC. | $118.77 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $102.75 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $101.05 | 2025 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $81.27 | 2023-2025 | Keytruda |
| Lilly USA, LLC | $72.76 | 2025 | Zepbound |
| Covis Pharma Gmbh | $71.01 | 2021-2022 | |
| Shire North American Group INC | $67.83 | 2019 | |
| Mayne Pharma Commercial LLC | $65.47 | 2020-2022 | |
| Noctrix Health, INC. | $46.40 | 2025 | Nidra |
| Csl Behring | $34.34 | 2019 | |
| Circassia INC. | $31.17 | 2019 | |
| Inspire Medical Systems, INC. | $26.45 | 2025 | Inspire |
| Astellas Pharma US INC | $21.87 | 2019 | |
| Axsome Therapeutics, INC. | $20.84 | 2024 | Sunosi |
| Boston Scientific Corporation | $15.22 | 2019 | |
| Ucb, INC. | $14.82 | 2021 | |
| Apria Healthcare LLC | $13.93 | 2021 | |
| Almatica Pharma LLC | $13.24 | 2023 | Loreev Xr |
| Nabriva Therapeutics, Plc | $13.18 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Bohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.